Given this, we speculate that the Sema6D expression level may affect the activation level of ERK and PI3K/AKT/mTOR signaling pathways in gastric cancer patients, thus affecting the proliferation and migration ability of gastric cancer cells. This evidence concerns the gene AKT1 and gastric cancer.